ALN-VSP02
ALN-VSP02-001
Phase 1 small_molecule completed
Quick answer
ALN-VSP02 for Solid Tumors is a Phase 1 program (small_molecule) at Alnylam Netherlands B.V. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Alnylam Netherlands B.V.
- Indication
- Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed